Reduced receptor editing in lupus-prone MRL/1pr mice

被引:29
|
作者
Lamoureux, Jennifer L. [1 ]
Watson, Lisa C. [1 ]
Cherrier, Marie [1 ]
Skog, Patrick [1 ]
Nemazee, David [1 ]
Feeney, Ann J. [1 ]
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 2007年 / 204卷 / 12期
关键词
D O I
10.1084/jem.20071268
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Journal of Experimental Medicine The initial B cell repertoire contains a considerable proportion of autoreactive specificities. The first major B cell tolerance checkpoint is at the stage of the immature B cell, where receptor editing is the primary mode of eliminating self-reactivity. The cells that emigrate from the bone marrow have a second tolerance checkpoint in the transitional compartment in the spleen. Although it is known that the second checkpoint is defective in lupus, it is not clear whether there is any breakdown in central B cell tolerance in the bone marrow. We demonstrate that receptor editing is less efficient in the lupus-prone strain MRL/lpr. In an in vitro system, when receptor-editing signals are given to bone marrow immature B cells by antiidiotype antibody or after in vivo exposure to membrane-bound self-antigen, MRL/lpr 3-83 transgenic immature B cells undergo less endogenous rearrangement and up-regulate recombination activating gene messenger RNA to a lesser extent than B10 transgenic cells. CD19, along with immunoglobulin M, is down-regulated in the bone marrow upon receptor editing, but the extent of down-regulation is fivefold less in MRL/lpr mice. Less efficient receptor editing could allow some autoreactive cells to escape from the bone marrow in lupus-prone mice, thus predisposing to autoimmunity.
引用
收藏
页码:2853 / 2864
页数:12
相关论文
共 50 条
  • [21] Alterations in leucocyte trafficking in lupus-prone mice:: an examination of the MRL/faslpr mouse
    Hickey, MJ
    IMMUNOLOGY AND CELL BIOLOGY, 2003, 81 (05): : 390 - 396
  • [22] Treatment of Lupus-prone MRL-lpr Mice with the Mitochondrial Antioxidant MitoQ
    Budd, Ralph
    Fortner, Karen
    Blanco, Luz
    Kaplan, Mariana
    Perl, Andras
    Busliewicz, Iwona
    MacPherson, Greg
    Murphy, Mike
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [23] MONOCLONAL RHEUMATOID FACTORS (RF) FROM MRL/MP-1PR/1PR (MRL/1) MICE
    BALDERAS, RS
    DIXON, FJ
    THEOFILOPOULOS, AN
    FEDERATION PROCEEDINGS, 1983, 42 (05) : 1212 - 1212
  • [24] IMMUNE MODULATING EFFECT OF DIMETHYLSULFOXIDE IN MRL/1PR MICE
    WYSENBEEK, AJ
    LOURIE, S
    WEINBERGER, A
    SCHOENFELD, N
    PICK, AI
    PECHT, M
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1986, 22 (12): : 932 - 932
  • [25] INVIVO EFFECTS OF DIETHYLDITHIOCARBAMATE ON AUTOIMMUNE MRL-1PR/1PR MICE
    HALPERN, M
    YOCUM, D
    CLINICAL RESEARCH, 1989, 37 (01): : A123 - A123
  • [26] INVIVO EFFECTS OF DIETHYLDITHIOCARBAMATE ON AUTOIMMUNE MRL-1PR/1PR MICE
    HALPERN, M
    YOCUM, D
    CLINICAL RESEARCH, 1989, 37 (02): : A508 - A508
  • [27] DEOXYSPERGUALIN THERAPY IN AUTOIMMUNE MRL/1PR MICE SUFFERING ADVANCED LUPUS-LIKE DISEASE
    NEMOTO, K
    MAE, T
    SUGAWARA, Y
    HAYASHI, M
    ABE, F
    TAKEUCHI, T
    JOURNAL OF ANTIBIOTICS, 1990, 43 (12): : 1590 - 1596
  • [28] HUMAN LUPUS AND MRL 1PR/1PR SERA SHARE SEQUENTIAL AUTOANTIGENIC DETERMINANTS ON THE SMALL RIBONUCLEOPROTEIN SM D
    JAMES, JA
    HARLEY, JB
    CLINICAL RESEARCH, 1993, 41 (02): : A246 - A246
  • [29] An intrinsic genetic defect in lupus-prone MRL mice leads to immunoglobulin heavy chain receptor replacement.
    Klonowski, KD
    Monestier, M
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S55 - S55
  • [30] Serum soluble MD-1 levels increase with disease progression in autoimmune prone MRL1pr/1pr mice
    Sasaki, Sumiyo
    Nagai, Yoshinori
    Yanagibashi, Tsutomu
    Watanabe, Yasuharu
    Ikutani, Masashi
    Kariyone, Ai
    Tsuneyama, Koichi
    Hirai, Yoshikatsu
    Takatsu, Kiyoshi
    MOLECULAR IMMUNOLOGY, 2012, 49 (04) : 611 - 620